CAS number：1174122-54-3 molecular formula：C19H18F6N4O3
Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research. In Vitro Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid
| Chinese alias | 瑞格列汀 | ||
| English alias | Retagliptin | 328C4R3P9L | Imidazo[1,5-a]pyrazine-1-carboxylic acid, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-, methyl ester,phosphate (1:1) | HY-112668A | methyl 7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl | ||
| CAS number | 1174122-54-3 | molecular formula | C19H18F6N4O3 |
| molecular weight | 464.36 g/mol | Exact mass | ≥98% |
| PSA | 90.500 Ų | logp | 1.500 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
